Eli Lilly & Company recalls Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial; Diluent for Glucagon, 1 mL syringe.…

Recall date

September 24, 2021

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0009-2022

FDA classification

Class I

Brand / firm

Eli Lilly & Company

Sold / distributed

Nationwide with the USA and Puerto Rico; Canada, Argentina, Costa Rica, Mexico

Why it was recalled

SUBPOTENT DRUG: Vial contained a liquid substance, instead of the expected powder substance. There was also a lack of full drug effect upon administration.

Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.

What was recalled

Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial; Diluent for Glucagon, 1 mL syringe. Rx only, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285; Glucagon, NDC: 0002-8031-01